1. Home
  2. QLGN vs AUMN Comparison

QLGN vs AUMN Comparison

Compare QLGN & AUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • AUMN
  • Stock Information
  • Founded
  • QLGN 1996
  • AUMN 1996
  • Country
  • QLGN United States
  • AUMN United States
  • Employees
  • QLGN N/A
  • AUMN N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • AUMN Precious Metals
  • Sector
  • QLGN Health Care
  • AUMN Basic Materials
  • Exchange
  • QLGN Nasdaq
  • AUMN Nasdaq
  • Market Cap
  • QLGN 3.4M
  • AUMN 4.1M
  • IPO Year
  • QLGN N/A
  • AUMN 1997
  • Fundamental
  • Price
  • QLGN $4.18
  • AUMN $0.12
  • Analyst Decision
  • QLGN
  • AUMN Strong Buy
  • Analyst Count
  • QLGN 0
  • AUMN 1
  • Target Price
  • QLGN N/A
  • AUMN $1.50
  • AVG Volume (30 Days)
  • QLGN 54.9K
  • AUMN 312.0K
  • Earning Date
  • QLGN 11-14-2024
  • AUMN 11-19-2024
  • Dividend Yield
  • QLGN N/A
  • AUMN N/A
  • EPS Growth
  • QLGN N/A
  • AUMN N/A
  • EPS
  • QLGN N/A
  • AUMN N/A
  • Revenue
  • QLGN N/A
  • AUMN $300,000.00
  • Revenue This Year
  • QLGN N/A
  • AUMN $254.39
  • Revenue Next Year
  • QLGN N/A
  • AUMN $32.53
  • P/E Ratio
  • QLGN N/A
  • AUMN N/A
  • Revenue Growth
  • QLGN N/A
  • AUMN N/A
  • 52 Week Low
  • QLGN $3.34
  • AUMN $0.11
  • 52 Week High
  • QLGN $30.50
  • AUMN $0.79
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 43.01
  • AUMN 16.41
  • Support Level
  • QLGN $3.53
  • AUMN $0.08
  • Resistance Level
  • QLGN $4.39
  • AUMN $0.18
  • Average True Range (ATR)
  • QLGN 0.33
  • AUMN 0.04
  • MACD
  • QLGN 0.06
  • AUMN -0.02
  • Stochastic Oscillator
  • QLGN 50.98
  • AUMN 15.00

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About AUMN Golden Minerals Company

Golden Minerals Co is an exploration stage company engaged in the mining, construction, and exploration of precious metals and mineral properties. It owns and operates Velardena and Chicago precious metals mining properties and associated oxide and sulfide processing plants in the State of Durango, Mexico, the El Quevar exploration property in the province of Salta, Argentina, and a diversified portfolio of precious metals and other mineral exploration properties located in or near historical precious metals producing regions of Mexico. The company's business is structured into two divisions, Mexico operations, and Corporate Exploration and Other.

Share on Social Networks: